Clinical Trial Update: Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sorafenib tosylate with or without pravastatin in liver cancer with cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Pravastatin (pravastatin)
• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Liver Cancer | Phase 3 | Status: COMPLETED